MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring System

Glucose Oxidase, Glucose

APEX BIO TECHNOLOGY CORP

The following data is part of a premarket notification filed by Apex Bio Technology Corp with the FDA for Meg-2b Blood Glucose Monitoring System, Meg-2b Pro Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK143750
510k NumberK143750
Device Name:MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring System
ClassificationGlucose Oxidase, Glucose
Applicant APEX BIO TECHNOLOGY CORP NO. 7, LI-HSIN ROAD V HSINCHU SCIENCE PARK Hsinchu,  TW 30078
ContactHsue-mei Lee
CorrespondentHsue-mei Lee
APEX BIO TECHNOLOGY CORP NO. 7, LI-HSIN ROAD V HSINCHU SCIENCE PARK Hsinchu,  TW 30078
Product CodeCGA  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-12-31
Decision Date2015-05-07
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.